Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TADALAFIL
- Management of OAB in Female Patients .
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
- Efficacy and Safety of Focused Shockwave Therapy Plus Tadalafil vs Tadalafil Alone in Patient With Erectile Dysfunction
- Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study
- Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones
- Single-arm, Window Trial of Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer
- A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
- Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
- The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transrectal Ultrasound-guided (TRUS) Prostate Biopsy
- A Phase 3 Study of the Efficacy and Safety of AR1001 in Participants With Early AD
- Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
- Investigational and Comparative Study in the Management of Diabetic Nephropathy
- Natesto Testosterone Nasal Gel for Hypogonadal Men
- Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response
- Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction
- Efficiency of Tadalafil for Management of Female Sexual Dysfunction
- (Phosphodiesterase 5 Inhibitors & α-blockers): Single Versus Combined Therapy in Benign Prostatic Hyperplasia
- A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participants
- Study of Tadalafil vs. Placebo for Improving Hemodynamics and End-Organ Dysfunction in Fontan Physiology
- Shock Wave vs. On-demand Tadalafil for Erectile Dysfunction
- Tadalafil as Adjuvant Therapy for DMD
- Improving Cerebral Blood Flow and Cognition in Patients With Cerebral Small Vessel Disease. The ETLAS-2 Trial
- Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract Symptoms: a Randomized Controlled Trial
- A Randomized Controlled Double-Blind Trial for Prevention of Recurrent Ischemic Priapism in Men With Sickle Cell Disease: A Pilot Study
- Endocan Level in Patients With Erectile Dysfunction and Relationship With Tadalafil Treatment
- Effects of Single Dose Tadalafil on Urethral and Anal Closure Function
- Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation
- The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
- The Phosphodiesterase 5 Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
- Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
- Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
- Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
- The Use of Tadalafil in Confirmed COVID-19 Pneumonia.
- A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers
- Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
- Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone.
- Effect of PDE5 Inhibition on Adipose Metabolism in Humans
- Comparative Study Between Tadalafil Versus Tamsulosin as a Medical Expulsive Therapy for Lower Ureteric Stones
- Combined Effect of Continuous and Interval in Addition to Tadalafil Drug on Erectile Dysfunction
- A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil
- Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.
- Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension
- Management of Prostatodynia in Younger Patients With Non-ablative Erbium:YAG Intraurethral Laser
- Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD).
- Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction
- A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants
- A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants
- PDE5i Use in Renal Transplant Recipients
- Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC
- Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)
- Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
- Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II
- Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
- Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction
- Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Initiative to Minimize Disparities in Postoperative Prostate Cancer Care
- Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
- Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
- Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil
- Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck
- Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment
- A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjects
- The Safety of Dapoxetine/Tadalafil Combination Therapy
- Hookah Smoking, Carbon Monoxide, and Coronary Endothelial Function
- A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients
- Tadalafil in Becker Muscular Dystrophy
- Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function
- Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
- Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy
- Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)
- Effect of Tadalafil on Erectile Dysfunction Treatment and QOL Improvement Effect (by SF-12) in Andropause Patients With Erectile Dysfunction
- Mirabegron For Erectile Dysfunction
- Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
- The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction
- A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects
- PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction
- Effect of Tadalafil on Cerebral Large Arteries in Stroke
- A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects
- Endocrine Cardiomyopathy: Response to Cyclic GMP PDE5 Inhibitors in Acromegaly Cardiomyopathy
- Endocrine Cardiomyopathy in Cushing Syndrome: Response to Cyclic GMP PDE5 inhibitOrs
- Effects on Insulin Resistance With Tadalafil in Type 2 Diabetes - a Double-blind, Placebo-controlled Crossover Study
- Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.
- The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
- Daily Tadalafil on Body Fat and Lean Mass
- PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC
- Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones
- Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial
- A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).
- Safety and Pharmacokinetic Characteristics of DKF-313
- A Study of LY2623091 in Healthy Participants
- Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers
- Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms
- CKD-397 Drug-drug Interaction Study (A)
- CKD-397 Drug-drug Interaction Study (B)
- Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin
- Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
- A Study of Tadalafil (LY450190) in Chinese Men With Erectile Dysfunction
- Diabetes & Vardenafil
- Tadalafil in Becker Muscular Dystrophy
- A Study of LY2623091 in Participants With High Blood Pressure
- Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)
- Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 Inhibitor
- Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage
- Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride
- A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
- Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
- Chemoimmunotherapy and Radiation in Pancreatic Cancer
- A Study of Tadalafil for Duchenne Muscular Dystrophy
- Tadalafil for Pulmonary Hypertension Due to Chronic Lung Disease
- Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma
- A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
- REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
- Tadalafil Effects in Left Ventricle Diastolic Dysfunction in Resistant Hypertensive Patients
- A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue
- A Randomized Trial of Udenafil Therapy in Patients With Heart Failure With Preserved Ejection Fraction [ULTIMATE-HFpEF]
- PDE Inhibitors in DMD Study (Acute Dosing Study)
- A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma
- Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
- A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
- Phase 3 Study of Tadalafil Once-Daily in Asian Men With Benign Prostatic Hyperplasia (BPH)
- A Trial of Tadalafil and Glycemic Traits
- A Bioavailability Study of LY2452473 and Tadalafil
- Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
- Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
- A Study of Tadalafil and Sildenafil in Men With Erectile Dysfunction in China
- Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
- Tadalafil for Sarcoidosis Associated Pulmonary Hypertension
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
- Treprostinil Combined With Tadalafil for Pulmonary Hypertension
- Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients
- Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study
- Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot Study
- A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses
- Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
- Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
- Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?
- A Study of Tadalafil in Benign Prostatic Hyperplasia
- A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
- A Study of LY900010 in Erectile Dysfunction
- A Study in Benign Prostatic Hyperplasia
- A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms
- A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors
- A Study in Erectile Dysfunction
- A Study in Patients With Erectile Dysfunction
- A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
- L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors
- Tadalafil in Becker Muscular Dystrophy
- Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males
- Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension
- Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
- Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
- A Study of Tadalafil After Radical Prostatectomy
- A Study of Tadalafil in Men With Benign Prostatic Hyperplasia
- Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
- A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
- PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
- Multinational Study to Evaluate Tadalafil in Asian Men With Signs and Symptoms of Benign Prostatic Hyperplasia
- A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia
- A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers
- Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx
- Effect of Tadalafil Once a Day in Men With Erectile Dysfunction
- A Study in Erectile Dysfunction
- Study to Treat Patients Who Have Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) With Tadalafil Daily
- Tadalafil for the Treatment of Raynaud's
- Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension
- A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
- Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi and PE5i
- A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.
- The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
- Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.
- Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia
- Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)
- A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil
- Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
- Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
- Efficacy of Udenafil After Radical Resection for Sigmoid Colon and Rectal Cancer
- Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs
- Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
- Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects
- Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection
- To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking
- Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection
- To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections
- Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection
- Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations
- Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection
- Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection
- Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men
- Tadalafil for Treatment of Priapism in Men With Sickle Cell Anemia
- Efficacy and Safety Study of Combined Oral and Injection Therapy for Erectile Dysfunction
- Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
- The Pharmacological Basis for the Increase in Visual Time Constants Induced by Single Oral Doses of Sildenafil
- Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
- Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction
- Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury
- Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
- Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
- A Study of Semen Characteristics After 9 Months of Daily Tadalafil 20 mg
- A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction
- Efficacy and Safety of Tadalafil in Hemodialysis Patients
- A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months
- Prevention of High Altitude Pulmonary Edema
- Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
- Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
- Tadalafil in Subjects With Mild to Moderate Hypertension
- PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension
- A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer
- Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying
Clinical trials list
click for details